Communication

Actualités

Samabriva is set to become a world leader in precision biomanufacturing of complex molecules

13 décembre 2023
Nos adhérents

Amiens (France), December 2023 – The French biotechnology company Samabriva has successfully completed a Series-A round of financing to secure an investment of nearly €4 million. Its innovative plant-based bioproduction process has the potential to transform production of high value molecules* – such as natural active molecules (secondary metabolites) and recombinant proteins – for the pharmaceutical and cosmetic sectors. Several specialist biotech business angels have joined this round of funding. Alongside their financial investment, they will bring a wealth of knowledge to help transform Samabriva into a leading CDMO. The immediate focus will be on the production of Active Pharmaceutical Ingredients (API) using confined and controlled plant-based expression systems. To know more